Answer
Nausea and vomiting are very common with remifentanil hydrochloride, affecting at least 1 in 10 patients, and these adverse events resolve within minutes of discontinuing administration or decreasing its rate.
Sources for this answer
- Remifentanil 1mg Powder for Concentrate for Solution for Injection or InfusionWockhardt UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 6Document updated
Sources checked